Skip to main content
Open Access Publications from the University of California

UC San Diego

UC San Diego Electronic Theses and Dissertations bannerUC San Diego

Identification and design of small molecules that associate with aggregated Alzheimer's-related beta-amyloid peptides


Aggregated beta-amyloid peptides have been identified as a pathological hallmark of Alzheimer's Disease (AD). Presented in this dissertation is the identification, evaluation, and design of small molecules that bind to aggregated beta-amyloid peptides. First, this dissertation describes the development of a parallel assay to rapidly screen small- to medium-sized libraries of molecules for their ability to bind to aggregated beta-amyloid(1-42) peptides. It also describes the extension of this assay to identify molecules that associate with two other amyloidogenic peptides, beta-amyloid(1-40) and alpha- synuclein(1-140), which revealed some selectivity for the association of specific small molecules to different amyloids. Second, it describes the development of amyloid- binding molecules that are capable of inhibiting protein- amyloid interactions, which may lead to a new therapeutic strategy for combating amyloid-based neurodegenerative disorders. Specifically, it describes the synthesis and evaluation of derivatives of thioflavin T, nicotine, and dopamine for their ability to inhibit protein-amyloid interactions. An extensive evaluation of derivatives of dopamine revealed the minimum structural requirements necessary to effectively inhibit the interaction between aggregated beta-amyloid peptides. Lastly, it describes studies towards the rational design of a novel class of imaging agents for AD based on information from the structure-binding studies with derivatives of dopamine.

Main Content
For improved accessibility of PDF content, download the file to your device.
Current View